ReviewFrontiers in immunology2021

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis.

Runsheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.